Latest Asx News

Epsilon Healthcare has commenced operations of its new pharmacy division and extended a key loan facility, signaling a strategic pivot towards integrated healthcare and financial stability after recent restructuring.

TT Investments has launched an unconditional $0.31 per security takeover bid for 360 Capital Group, aiming to delist the company from the ASX. The Independent Board Committee recommends acceptance amid significant premiums and looming governance changes.

Wisr Limited has announced an $11.4 million equity raise alongside an upgraded FY26 outlook and a non-binding term sheet to refinance its debt at lower interest rates, positioning the fintech lender for profitability in the second half of FY26.

Regal Asian Investments Limited has announced an on-market buy-back of its ordinary shares, set to run from November 2025 through November 2026, signaling a strategic move to manage its capital structure.

Renascor Resources has secured drilling approvals for its Bulloo Creek copper-cobalt-gold prospects and confirmed high-grade rare earth elements at Tumby Bay, while progressing uranium-copper targets at Marree.

QMines Limited has identified several significant gold targets at its Mount Mackenzie Gold Project through advanced reprocessing of magnetic data, with a maiden drilling program now in progress to test these promising zones.

Alliance Nickel’s binding offtake agreement with Stellantis is terminated due to missed milestones amid tough nickel market conditions, yet renegotiation talks signal ongoing partnership potential.

Metal Bank Limited has successfully closed a $2.42 million entitlement offer, bolstering its capacity to advance gold projects in Western Australia and critical minerals exploration in Queensland.

Piche Resources Limited has had its trading suspension lifted immediately following the announcement of a new capital raising initiative, signaling a fresh chapter for the mining company.

Piche Resources has successfully raised approximately AUD 2 million through an oversubscribed placement, attracting strong institutional interest and issuing free attaching options to support its Argentine exploration projects.

Mayne Pharma’s acquisition by Cosette Pharmaceuticals faces a regulatory delay as the Foreign Investment Review Board extends its approval deadline, pushing the court hearing to mid-November.

Alvo Minerals’ recent ground gravity survey at its Palma Project in Brazil has revealed three promising untested drill targets adjacent to the C1 deposit, potentially expanding its copper-zinc resource base.